Morris v. PLIVA, Inc.

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

• noting that any “useful reporting” resulting from adequate testing would “ostensibly consist of some sort of warning”
• noting that any “useful reporting” resulting from adequate testing would “ostensibly consist of some sort of warning”
• although generic drug manufacturers might have duty under federal law to alert FDA of need to strengthen warnings and labels, Louisiana tort law imposed no such duty
• plaintiff could not sue generic drug manufacturer for failing to use a label not required by the FDA
• “Whether a warning is placed on the label on the bottle or in letters to distributors, any state law duty requiring generic manufacturers to act unilaterally in this area is preempted by federal law.”

Source: CourtListener parenthetical corpus (CC0).

Cited by

26 cases in this archive cite this case; the 20 most cited are listed.

• Yanise Germain v. Teva Pharmaceuticals, USA, Inc
  Sixth Circuit· 2014-06-27· cited 104×
• Sarah Speed v. Wyeth Pharmaceuticals, Inc.
  Sixth Circuit· 2013-12-02· cited 79×
• Wagner v. Teva Pharmaceuticals USA, Inc.
  Seventh Circuit· 2016-10-18· cited 67×
• Andrea Guarino v. Wyeth, LLC
  Eleventh Circuit· 2013-06-25· cited 57×
• Reymond Meadaa v. K.A.P. Enterprises, L.L.C
  Fifth Circuit· 2014-07-01· cited 52×
• In Re Fosamax (Alendronate Sodium) Products Liability Litigation
  Third Circuit· 2014-04-30· cited 43×
• Eckhardt v. Qualitest Pharmaceuticals, Inc.
  Fifth Circuit· 2014-05-13· cited 30×
• Shirley Brinkley v. Pliva, Inc.
  Eighth Circuit· 2014-12-02· cited 28×
• Tina Johnson v. Teva Pharmaceuticals USA, Inc., et
  Fifth Circuit· 2014-07-11· cited 26×
• In Re Reglan Litigation
  Supreme Court of New Jersey· 2016-08-22· cited 24×
• Teva Pharmaceuticals USA, Inc. v. Superior Court
  California Court of Appeal· 2013-06-13· cited 14×
• Elmazouni v. Mylan, Inc.
  N.D. Texas· 2016-12-01· cited 10×
• Fulgenzi v. PLIVA, Inc.
  N.D. Ohio· 2015-10-23· cited 7×
• Chatman v. Pfizer, Inc.
  S.D. Mississippi· 2013-03-28· cited 7×
• Amin-Akbari v. City of Austin
  W.D. Texas· 2014-10-01· cited 6×
• Glover v. Bausch & Lomb, Inc.
  Supreme Court of Connecticut· 2022-06-07· cited 6×
• Stephens v. Teva Pharmaceuticals, U.S.A., Inc.
  N.D. Alabama· 2014-10-01· cited 4×
• Weeks v. Wyeth, Inc.
  M.D. Alabama· 2015-08-03· cited 3×
• In re Testosterone Replacement Therapy Products Liability Litigation Coordinated Pretrial Proceedings
  N.D. Illinois· 2015-11-09· cited 3×
• Wolters Kluwer Health, Inc. v. Dorothy Tanner
  Court of Appeals of Georgia· 2015-11-20· cited 2×

Cites

13 cases in this archive are cited by this case.

• Bell Atlantic Corp. v. Twombly
  Supreme Court· 2007-05-21· cited 146,720×
• Wyeth v. Levine
  Supreme Court· 2009-03-04· cited 1,294×
• Buckman Co. v. Plaintiffs' Legal Committee
  Supreme Court· 2001-02-21· cited 956×
• Cuvillier v. Taylor
  Fifth Circuit· 2007-10-05· cited 870×
• Schiller v. Physicians Resource Group Inc.
  Fifth Circuit· 2003-08-29· cited 792×
• Rosenzweig v. Azurix Corp.
  Fifth Circuit· 2003-06-13· cited 527×
• PLIVA, Inc. v. Mensing
  Supreme Court· 2011-06-23· cited 428×
• Jebaco, Inc. v. Harrah's Operating Co., Inc.
  Fifth Circuit· 2009-10-30· cited 122×
• Smith v. Wyeth, Inc.
  Sixth Circuit· 2011-09-22· cited 62×
• Mensing v. Wyeth, Inc.
  Eighth Circuit· 2009-11-27· cited 56×
• Bartlett v. Mutual Pharmaceutical Co., Inc.
  First Circuit· 2012-05-02· cited 22×
• Mensing v. Wyeth, Inc.
  Eighth Circuit· 2011-09-29· cited 11×
• Demahy v. Actavis, Inc.
  Fifth Circuit· 2011-08-22· cited 7×